Logie A W, Stowers J M
Br Med J. 1975 Aug 30;3(5982):514-5. doi: 10.1136/bmj.3.5982.514.
Glibornuride is an addition to the second-generation sulphonylureas, that has been shown in clinical trials to be effective and non-toxic. Twenty-three diabetics who were poorly controlled on other oral hypoglycaemic agents and seven newly diagnosed diabetics were treated with glibornuride. The efficacy and lack of toxicity of this drug was confirmed, but there was no evidence to suggest that it is significantly more potent than other sulphonylureas. It does not seem to represent a significant therapeutic advance.
格列波脲是第二代磺酰脲类药物中的一种,临床试验表明其有效且无毒。23名使用其他口服降糖药控制不佳的糖尿病患者和7名新诊断的糖尿病患者接受了格列波脲治疗。该药物的有效性和无毒性得到了证实,但没有证据表明它比其他磺酰脲类药物更有效。它似乎并没有带来显著的治疗进展。